TORONTO, May 28 /CNW/ - DRAXIS Health Inc. ("DRAXIS") (TSX: DAX) (NASDAQ:
DRAX) announced today the completion of the statutory arrangement under which
all of DRAXIS' common shares have been acquired by an indirect wholly-owned
subsidiary of Jubilant Organosys Ltd. for US$6.00 per common share. As a
result, DRAXIS common stock is expected to cease trading on the NASDAQ Global
Market and on the Toronto Stock Exchange at market close on Thursday, May 29,
2008, and will no longer be listed on these stock exchanges.
